[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @FelixSchreibe13 Moody Moody posts on X about $hrow, $qure, $intr, $cmps the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1105547841664102401/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +28% - X Months XXXXXXX +44% - X Year XXXXXXX +225% ### Mentions: XX [#](/creator/twitter::1105547841664102401/posts_active)  - X Week XX -XX% - X Month XX -XX% - X Months XXX -XXXX% - X Year XXX +113% ### Followers: XXX [#](/creator/twitter::1105547841664102401/followers)  - X Week XXX +1.40% - X Month XXX +5% - X Months XXX +90% - X Year XXX +105% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1105547841664102401/influencer_rank)  ### Social Influence [#](/creator/twitter::1105547841664102401/influence) --- **Social category influence** [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [stocks](/list/stocks) [automotive brands](/list/automotive-brands) **Social topic influence** [$hrow](/topic/$hrow) #24, [$qure](/topic/$qure) #28, [$intr](/topic/$intr), [$cmps](/topic/$cmps) #12, [$soipa](/topic/$soipa) #9, [stocks](/topic/stocks), [$clpt](/topic/$clpt), [$28b](/topic/$28b), [$hood](/topic/$hood), [$cmbax](/topic/$cmbax) **Top accounts mentioned or mentioned by** [@pedrolamento](/creator/undefined) [@greentardscycle](/creator/undefined) [@hiddemulder2](/creator/undefined) [@dakotastwits](/creator/undefined) [@maxfichtner](/creator/undefined) [@biohazard3737](/creator/undefined) [@sharpeshark](/creator/undefined) [@petermantas](/creator/undefined) [@elonmusk](/creator/undefined) [@thelonginvest](/creator/undefined) [@jerrycap](/creator/undefined) [@pharmdca](/creator/undefined) [@mathcoredad](/creator/undefined) [@michiganvalue](/creator/undefined) [@richtrades100](/creator/undefined) [@thinkbto](/creator/undefined) [@501stlegion4](/creator/undefined) [@co2klima](/creator/undefined) [@ralfwabe](/creator/undefined) [@rainerklute](/creator/undefined) **Top assets mentioned** [uniQure N.V. (QURE)](/topic/$qure) [Interlay (INTR)](/topic/$intr) [Robinhood Markets, Inc. (HOOD)](/topic/$hood) [Bitcoin Incognito (XBI)](/topic/$xbi) [Affiliated Managers Group (AMG)](/topic/$amg) ### Top Social Posts [#](/creator/twitter::1105547841664102401/posts) --- Top posts by engagements in the last XX hours "$CLPT is the one ring binding the five great neurodegenerative diseases enabling and controlling the therapies that seek to master them" [X Link](https://x.com/FelixSchreibe13/status/1974199828382167464) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-03T19:48Z XXX followers, 2419 engagements "$INTR counts 7.9M brokerage clients with $28B in assets about 1/3 of Robinhoods users and 1/10 of its assets. Yet Robinhood trades at 30x Inters valuation and thats just one of many business lines" [X Link](https://x.com/FelixSchreibe13/status/1967637519794835721) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-09-15T17:11Z XXX followers, 1059 engagements "With high-risk asymmetric bets you often only need one to hit. Ive written off Capricor $CMPS and $CMB.AX are still in the race and in the green and $QURE has almost quadrupled covering nearly the entire stake across all four bets on its own. All stakes were small" [X Link](https://x.com/FelixSchreibe13/status/1970868740108775515) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-09-24T15:11Z XXX followers, XXX engagements "When the shipwrecked begin to swim again the tide has risen. $MRVI $MXCT $XBI" [X Link](https://x.com/FelixSchreibe13/status/1974125637138006330) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-03T14:53Z XXX followers, XXX engagements "$SOI.PA Soitecs Edge & Cloud AI segment makes up XX% of FY25 sales (216m). With silicon photonics PICs growing XX% CAGR (2329 Yole) Soitec as leading 300mm substrate supplier should capture 2535% CAGR. Edge from Smart Cut IP + scale as dominant provider" [X Link](https://x.com/FelixSchreibe13/status/1961004966618792262) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-08-28T09:56Z XXX followers, 1446 engagements "I focus on stocks I hold for XX years and Im very satisfied with how my portfolio and style have evolved. Many picks still have long growth potential. Biggest mistake: overweighting $CRNT strong company but highly cyclical business" [X Link](https://x.com/FelixSchreibe13/status/1971130228870467632) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-09-25T08:30Z XXX followers, XXX engagements "Approximately XX% of the portfolio consists of a large number of underweight companies such as: $NTG.DE $SBS.DE $SOI.PA $ZAL.DE $CWC.DE $MED.DE $QURE $CMPS $ACHV $MDP.TO" [X Link](https://x.com/FelixSchreibe13/status/1971130231806451833) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-09-25T08:30Z XXX followers, XXX engagements "1 Platform / Network Effect Moat (🔹🔹🔹🔹): $HROW s position as the first-call commercialization partner creates a self-reinforcing loop more partners bring more products data and customers making Harrow the default gateway for ophthalmic drug launches in the U.S" [X Link](https://x.com/FelixSchreibe13/status/1977385218836193345) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XXX engagements "2 Secular Tailwinds (🔹🔹🔹🔹): An aging population rising screen time and growing eye disease prevalence expand Harrows addressable market. These durable long-term trends lift overall demand and magnify the impact of Harrows existing moats" [X Link](https://x.com/FelixSchreibe13/status/1977385221881274618) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XX engagements "The success of $QURE marks the biggest commercial breakthrough in gene therapy history imo. Its triggering a new boom. Mid-year I flagged two small caps set to gain from the coming cell & gene therapy wave since then $OXB.L +100% and $CYRX +50%. Links below" [X Link](https://x.com/FelixSchreibe13/status/1974074430109462573) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-03T11:29Z XXX followers, XXX engagements "Shareholder base changes with each valuation level and so does the stocks behavior. With average holding periods down to X months short-term reactions are normal. $HROW is X year from revenues justifying a $2B valuation. Yesterdays news is irrelevant these are buy levels" [X Link](https://x.com/FelixSchreibe13/status/1976288931462185462) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-09T14:09Z XXX followers, XXX engagements "$HROW s goal of reaching at least $XXX M in revenue by Q4 2027 is supported not only by a management team with a proven track record and strong organic growth momentum but also by durable moats reinforced by powerful secular tailwinds in ophthalmology. X - 5" [X Link](https://x.com/FelixSchreibe13/status/1977385216399356164) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XXX engagements "3Economies of Scale / Scope (🔹🔹🔹): $HROW s nationwide ophthalmic infrastructure allows new products to ride on existing sales logistics and compliance costs. Each addition boosts margins and cross-selling a scalable cost-efficient edge few competitors can match" [X Link](https://x.com/FelixSchreibe13/status/1977385224762794334) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XXX engagements "4IP / Exclusivity (🔹🔹): $HROW holds exclusive U.S. rights and brands for several FDA-approved ophthalmic drugs providing temporary pricing power and market protection through NDA/IP rights and unique formulations" [X Link](https://x.com/FelixSchreibe13/status/1977385227786883187) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XXX engagements "5Relationship / Lock-in (🔹🔹): By serving as a one-stop supplier for ophthalmologists $HROW builds trust and convenience. Its broad portfolio and reliable service create switching costs and enable efficient cross-selling within the same customer base" [X Link](https://x.com/FelixSchreibe13/status/1977385230525759967) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-12T14:45Z XXX followers, XXX engagements "$CRMD seems very cheap for a reason. But Fears of a 2026 cliff are overstated imo. TDAPA ends mid-2026 but a X y post-TDAPA add-on keeps reimbursement intact. Margins may normalize not collapse as LDO adoption and Melinta diversification sustain growth beyond the transition" [X Link](https://x.com/FelixSchreibe13/status/1980278911234716156) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-20T14:24Z XXX followers, 1096 engagements "The market doubts $INTR will hit its 2027 targets including $900M net income. With todays $4B market cap even achieving XX% of that could imply a 23x upside" [X Link](https://x.com/FelixSchreibe13/status/1980304119710765545) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-20T16:04Z XXX followers, XXX engagements "@brianjohn0311 @mmpadellan That's the level of an undereducated 14-year-old adolescent teenager. Thats the press secretary of the White House. Unbelievable" [X Link](https://x.com/FelixSchreibe13/status/1980361460187558352) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-20T19:52Z XXX followers, XXX engagements "Another defense idea that doubled since then. In addition the company specializes in critical materials. However the stock was always valued based on the current price of lithium. $AMG" [X Link](https://x.com/FelixSchreibe13/status/1980523930944450998) [@FelixSchreibe13](/creator/x/FelixSchreibe13) 2025-10-21T06:37Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@FelixSchreibe13 Moody
Moody posts on X about $hrow, $qure, $intr, $cmps the most. They currently have XXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX +28%
- X Months XXXXXXX +44%
- X Year XXXXXXX +225%
Mentions: XX #
- X Week XX -XX%
- X Month XX -XX%
- X Months XXX -XXXX%
- X Year XXX +113%
Followers: XXX #
- X Week XXX +1.40%
- X Month XXX +5%
- X Months XXX +90%
- X Year XXX +105%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance cryptocurrencies stocks automotive brands
Social topic influence $hrow #24, $qure #28, $intr, $cmps #12, $soipa #9, stocks, $clpt, $28b, $hood, $cmbax
Top accounts mentioned or mentioned by @pedrolamento @greentardscycle @hiddemulder2 @dakotastwits @maxfichtner @biohazard3737 @sharpeshark @petermantas @elonmusk @thelonginvest @jerrycap @pharmdca @mathcoredad @michiganvalue @richtrades100 @thinkbto @501stlegion4 @co2klima @ralfwabe @rainerklute
Top assets mentioned uniQure N.V. (QURE) Interlay (INTR) Robinhood Markets, Inc. (HOOD) Bitcoin Incognito (XBI) Affiliated Managers Group (AMG)
Top Social Posts #
Top posts by engagements in the last XX hours
"$CLPT is the one ring binding the five great neurodegenerative diseases enabling and controlling the therapies that seek to master them"
X Link @FelixSchreibe13 2025-10-03T19:48Z XXX followers, 2419 engagements
"$INTR counts 7.9M brokerage clients with $28B in assets about 1/3 of Robinhoods users and 1/10 of its assets. Yet Robinhood trades at 30x Inters valuation and thats just one of many business lines"
X Link @FelixSchreibe13 2025-09-15T17:11Z XXX followers, 1059 engagements
"With high-risk asymmetric bets you often only need one to hit. Ive written off Capricor $CMPS and $CMB.AX are still in the race and in the green and $QURE has almost quadrupled covering nearly the entire stake across all four bets on its own. All stakes were small"
X Link @FelixSchreibe13 2025-09-24T15:11Z XXX followers, XXX engagements
"When the shipwrecked begin to swim again the tide has risen. $MRVI $MXCT $XBI"
X Link @FelixSchreibe13 2025-10-03T14:53Z XXX followers, XXX engagements
"$SOI.PA Soitecs Edge & Cloud AI segment makes up XX% of FY25 sales (216m). With silicon photonics PICs growing XX% CAGR (2329 Yole) Soitec as leading 300mm substrate supplier should capture 2535% CAGR. Edge from Smart Cut IP + scale as dominant provider"
X Link @FelixSchreibe13 2025-08-28T09:56Z XXX followers, 1446 engagements
"I focus on stocks I hold for XX years and Im very satisfied with how my portfolio and style have evolved. Many picks still have long growth potential. Biggest mistake: overweighting $CRNT strong company but highly cyclical business"
X Link @FelixSchreibe13 2025-09-25T08:30Z XXX followers, XXX engagements
"Approximately XX% of the portfolio consists of a large number of underweight companies such as: $NTG.DE $SBS.DE $SOI.PA $ZAL.DE $CWC.DE $MED.DE $QURE $CMPS $ACHV $MDP.TO"
X Link @FelixSchreibe13 2025-09-25T08:30Z XXX followers, XXX engagements
"1 Platform / Network Effect Moat (🔹🔹🔹🔹): $HROW s position as the first-call commercialization partner creates a self-reinforcing loop more partners bring more products data and customers making Harrow the default gateway for ophthalmic drug launches in the U.S"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XXX engagements
"2 Secular Tailwinds (🔹🔹🔹🔹): An aging population rising screen time and growing eye disease prevalence expand Harrows addressable market. These durable long-term trends lift overall demand and magnify the impact of Harrows existing moats"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XX engagements
"The success of $QURE marks the biggest commercial breakthrough in gene therapy history imo. Its triggering a new boom. Mid-year I flagged two small caps set to gain from the coming cell & gene therapy wave since then $OXB.L +100% and $CYRX +50%. Links below"
X Link @FelixSchreibe13 2025-10-03T11:29Z XXX followers, XXX engagements
"Shareholder base changes with each valuation level and so does the stocks behavior. With average holding periods down to X months short-term reactions are normal. $HROW is X year from revenues justifying a $2B valuation. Yesterdays news is irrelevant these are buy levels"
X Link @FelixSchreibe13 2025-10-09T14:09Z XXX followers, XXX engagements
"$HROW s goal of reaching at least $XXX M in revenue by Q4 2027 is supported not only by a management team with a proven track record and strong organic growth momentum but also by durable moats reinforced by powerful secular tailwinds in ophthalmology. X - 5"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XXX engagements
"3Economies of Scale / Scope (🔹🔹🔹): $HROW s nationwide ophthalmic infrastructure allows new products to ride on existing sales logistics and compliance costs. Each addition boosts margins and cross-selling a scalable cost-efficient edge few competitors can match"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XXX engagements
"4IP / Exclusivity (🔹🔹): $HROW holds exclusive U.S. rights and brands for several FDA-approved ophthalmic drugs providing temporary pricing power and market protection through NDA/IP rights and unique formulations"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XXX engagements
"5Relationship / Lock-in (🔹🔹): By serving as a one-stop supplier for ophthalmologists $HROW builds trust and convenience. Its broad portfolio and reliable service create switching costs and enable efficient cross-selling within the same customer base"
X Link @FelixSchreibe13 2025-10-12T14:45Z XXX followers, XXX engagements
"$CRMD seems very cheap for a reason. But Fears of a 2026 cliff are overstated imo. TDAPA ends mid-2026 but a X y post-TDAPA add-on keeps reimbursement intact. Margins may normalize not collapse as LDO adoption and Melinta diversification sustain growth beyond the transition"
X Link @FelixSchreibe13 2025-10-20T14:24Z XXX followers, 1096 engagements
"The market doubts $INTR will hit its 2027 targets including $900M net income. With todays $4B market cap even achieving XX% of that could imply a 23x upside"
X Link @FelixSchreibe13 2025-10-20T16:04Z XXX followers, XXX engagements
"@brianjohn0311 @mmpadellan That's the level of an undereducated 14-year-old adolescent teenager. Thats the press secretary of the White House. Unbelievable"
X Link @FelixSchreibe13 2025-10-20T19:52Z XXX followers, XXX engagements
"Another defense idea that doubled since then. In addition the company specializes in critical materials. However the stock was always valued based on the current price of lithium. $AMG"
X Link @FelixSchreibe13 2025-10-21T06:37Z XXX followers, XXX engagements